74 related articles for article (PubMed ID: 8760334)
1. Signalling to p53: where does it all start?
Kastan MB
Bioessays; 1996 Aug; 18(8):617-9. PubMed ID: 8760334
[TBL] [Abstract][Full Text] [Related]
2. Death squads enlisted by the tumour suppressor p53.
Michalak E; Villunger A; Erlacher M; Strasser A
Biochem Biophys Res Commun; 2005 Jun; 331(3):786-98. PubMed ID: 15865934
[TBL] [Abstract][Full Text] [Related]
3. [Tumor suppressor gene p53: mechanisms of action in cell proliferation and death].
Mendoza-Rodríguez CA; Cerbón MA
Rev Invest Clin; 2001; 53(3):266-73. PubMed ID: 11496714
[TBL] [Abstract][Full Text] [Related]
4. [Cell cycle regulation after exposure to ionizing radiation].
Teyssier F; Bay JO; Dionet C; Verrelle P
Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
[TBL] [Abstract][Full Text] [Related]
5. Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 4: p53 signaling pathway.
Newton HB
Expert Rev Anticancer Ther; 2005 Feb; 5(1):177-91. PubMed ID: 15757449
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional control of human p53-regulated genes.
Riley T; Sontag E; Chen P; Levine A
Nat Rev Mol Cell Biol; 2008 May; 9(5):402-12. PubMed ID: 18431400
[TBL] [Abstract][Full Text] [Related]
7. Functional analysis of the p53 pathway in response to ionizing radiation in uveal melanoma.
Sun Y; Tran BN; Worley LA; Delston RB; Harbour JW
Invest Ophthalmol Vis Sci; 2005 May; 46(5):1561-4. PubMed ID: 15851551
[TBL] [Abstract][Full Text] [Related]
8. p53--a natural cancer killer: structural insights and therapeutic concepts.
Römer L; Klein C; Dehner A; Kessler H; Buchner J
Angew Chem Int Ed Engl; 2006 Oct; 45(39):6440-60. PubMed ID: 16983711
[TBL] [Abstract][Full Text] [Related]
9. The p53 tumour suppressor gene.
Steele RJ; Thompson AM; Hall PA; Lane DP
Br J Surg; 1998 Nov; 85(11):1460-7. PubMed ID: 9823903
[TBL] [Abstract][Full Text] [Related]
10. Function of the p53 gene: choice between life and death.
Chumakov PM
Biochemistry (Mosc); 2000 Jan; 65(1):28-40. PubMed ID: 10702638
[TBL] [Abstract][Full Text] [Related]
11. The p53 story: layers of complexity.
Braithwaite AW; Royds JA; Jackson P
Carcinogenesis; 2005 Jul; 26(7):1161-9. PubMed ID: 15817608
[TBL] [Abstract][Full Text] [Related]
12. Signaling to p53: breaking the posttranslational modification code.
Appella E; Anderson CW
Pathol Biol (Paris); 2000 Apr; 48(3):227-45. PubMed ID: 10858956
[TBL] [Abstract][Full Text] [Related]
13. Human p14(ARF)-mediated cell cycle arrest strictly depends on intact p53 signaling pathways.
Weber HO; Samuel T; Rauch P; Funk JO
Oncogene; 2002 May; 21(20):3207-12. PubMed ID: 12082636
[TBL] [Abstract][Full Text] [Related]
14. Post-translational modification of p53 and the integration of stress signals.
Meek DW
Pathol Biol (Paris); 1997 Dec; 45(10):804-14. PubMed ID: 9769944
[TBL] [Abstract][Full Text] [Related]
15. p53 mutation heterogeneity in cancer.
Soussi T; Lozano G
Biochem Biophys Res Commun; 2005 Jun; 331(3):834-42. PubMed ID: 15865939
[TBL] [Abstract][Full Text] [Related]
16. DNA damage-induced protein 14-3-3 sigma inhibits protein kinase B/Akt activation and suppresses Akt-activated cancer.
Yang H; Wen YY; Zhao R; Lin YL; Fournier K; Yang HY; Qiu Y; Diaz J; Laronga C; Lee MH
Cancer Res; 2006 Mar; 66(6):3096-105. PubMed ID: 16540659
[TBL] [Abstract][Full Text] [Related]
17. Molecular "rehabilitation" by rational drug targeting: the challenge of P53 in cancer treatment.
Tzatsos A; Papavassiliou AG
Anticancer Res; 1999; 19(5B):4353-6. PubMed ID: 10628400
[TBL] [Abstract][Full Text] [Related]
18. Functional inactivation of p53 by human T-cell leukemia virus type 1 Tax protein: mechanisms and clinical implications.
Tabakin-Fix Y; Azran I; Schavinky-Khrapunsky Y; Levy O; Aboud M
Carcinogenesis; 2006 Apr; 27(4):673-81. PubMed ID: 16308315
[TBL] [Abstract][Full Text] [Related]
19. Role of p53 and apoptosis in carcinogenesis.
Wang XW
Anticancer Res; 1999; 19(6A):4759-71. PubMed ID: 10697590
[TBL] [Abstract][Full Text] [Related]
20. [The p53 gene and protein in 2005: new results, promising opportunities].
Szoke D; Sipos F; Spisák S; Molnár B; Tulassay Z
Orv Hetil; 2005 Jul; 146(30):1587-94. PubMed ID: 16136736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
